Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15338695 | 0.83 | HPGD (0.55) | HPGDALDH1A1GAALMNAKDM4E | |
| SCHEMBL28958745 | 0.80 | HPGD (0.56) | HPGDALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL27482174 | 0.77 | LMNA (0.58) | HPGDALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL1683935 | 0.77 | PLA2G4A (0.56) | HPGDALDH1A1FAAHLMNAKDM4E | |
| N-Benzyldodecanamide SCHEMBL3977374 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH | |
| SCHEMBL5696750 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH | |
| SCHEMBL16714726 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH | |
| SCHEMBL2524088 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH | |
| Nonanoic Acid Benzylamide SCHEMBL3280214 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH | |
| SCHEMBL5471650 | 0.77 | EPHX2 (1.00) | EPHX2HPGDALDH1A1GAAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230094176-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENT AB (SE) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230094176-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC2, HDAC1 | EPHX2 3208/4885HPGD 1445/4885ALDH1A1 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.